CD45: a critical regulator in immune cells to predict severe and non-severe COVID-19 patients
- PMID: 33065551
- PMCID: PMC7655207
- DOI: 10.18632/aging.103941
CD45: a critical regulator in immune cells to predict severe and non-severe COVID-19 patients
Abstract
The ongoing outbreak of COVID-19 has been announced by the World Health Organization as a worldwide public health emergency. The aim of this study was to distinguish between severe and non-severe patients in early diagnosis. The results showed that the mortality of COVID-19 patients increased accompanied by age. Host factors CRP, IL-1β, hs-CRP, IL-8, and IL-6 levels in severe pneumonia patients were higher than in non-severe patients. CD3, CD8, and CD45 counts were decreased in COVID-19 patients. The results of this study suggest that the K-values of CD45 might be useful in distinguishing between severe and non-severe cases. The cut-off value for CD45 was -94.33. The K-values for CD45 in non-severe case were above the cut-off values, indicating a 100% prediction success rate for severe and non-severe cases following SARS-CoV-2 infection. The results confirmed that immune system dysfunction is a potential cause of mortality following COVID-19 infection, particularly for the elderly. CD45 deficiency dysfunction the naïve and memory T lymphocytes which may affects the long-term effectiveness of COVID-19 vaccines. K-values of CD45 might be useful in distinguishing between severe and non-severe cases in the early infection. May be CD45 could increase the diagnostic sensitivity.
Keywords: COVID-19; clinical characteristics; coronavirus disease 2019; immunopathology; pneumonia; severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Conflict of interest statement
Figures
Similar articles
-
Clinical Features of COVID-19 Patients with Diabetes and Secondary Hyperglycemia.J Diabetes Res. 2020 Aug 24;2020:3918723. doi: 10.1155/2020/3918723. eCollection 2020. J Diabetes Res. 2020. PMID: 33062712 Free PMC article.
-
Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay.J Appl Lab Med. 2020 Nov 1;5(6):1313-1323. doi: 10.1093/jalm/jfaa134. J Appl Lab Med. 2020. PMID: 32717060 Free PMC article.
-
Surviving COVID-19: A disease tolerance perspective.Sci Adv. 2020 Apr 29;6(18):eabc1518. doi: 10.1126/sciadv.abc1518. eCollection 2020 May. Sci Adv. 2020. PMID: 32494691 Free PMC article. No abstract available.
-
Early Insights into Immune Responses during COVID-19.J Immunol. 2020 Aug 1;205(3):555-564. doi: 10.4049/jimmunol.2000526. Epub 2020 Jun 8. J Immunol. 2020. PMID: 32513850 Review.
-
Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).J Biomed Sci. 2020 Jun 4;27(1):72. doi: 10.1186/s12929-020-00663-w. J Biomed Sci. 2020. PMID: 32498686 Free PMC article. Review.
Cited by
-
Significance of Catecholamine Biosynthetic/Metabolic Pathway in SARS-CoV-2 Infection and COVID-19 Severity.Cells. 2022 Dec 20;12(1):12. doi: 10.3390/cells12010012. Cells. 2022. PMID: 36611805 Free PMC article.
-
IL-10 and IL-12 (P70) Levels Predict the Risk of Covid-19 Progression in Hypertensive Patients: Insights From the BRACE-CORONA Trial.Front Cardiovasc Med. 2021 Jul 27;8:702507. doi: 10.3389/fcvm.2021.702507. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34386533 Free PMC article.
-
Abnormal myocardial enzymes in the prediction of mortality and hypertension in COVID-19 patients: a retrospective study.Aging (Albany NY). 2022 Nov 2;14(21):8585-8594. doi: 10.18632/aging.204362. Epub 2022 Nov 2. Aging (Albany NY). 2022. PMID: 36326681 Free PMC article.
-
The age again in the eye of the COVID-19 storm: evidence-based decision making.Immun Ageing. 2021 May 20;18(1):24. doi: 10.1186/s12979-021-00237-w. Immun Ageing. 2021. PMID: 34016150 Free PMC article.
-
Evaluation of the Levels of Peripheral CD3+, CD4+, and CD8+ T Cells and IgG and IgM Antibodies in COVID-19 Patients at Different Stages of Infection.Microbiol Spectr. 2022 Feb 23;10(1):e0084521. doi: 10.1128/spectrum.00845-21. Epub 2022 Feb 23. Microbiol Spectr. 2022. PMID: 35196808 Free PMC article.
References
-
- Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, et al., and China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382:727–33. 10.1056/NEJMoa2001017 - DOI - PMC - PubMed
-
- Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, Li J, Zhao D, Xu D, Gong Q, Liao J, Yang H, Hou W, Zhang Y. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020; 395:809–15. 10.1016/S0140-6736(20)30360-3 - DOI - PMC - PubMed
-
- Khot WY, Nadkar MY. The 2019 novel coronavirus outbreak – a global threat. J Assoc Physicians India. 2020; 68:67–71. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous